HR 9321
117th Congress
House
Health
Independent Drug Value Assessment Act
Introduced: November 16, 2022
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 17, 2022
Referred to the Subcommittee on Health.
Nov 16, 2022
Referred to the House Committee on Energy and Commerce.
Nov 16, 2022
Introduced in House
Plain-English summary
Independent Drug Value Assessment Act
This bill requires the Office of the Assistant Secretary for Planning and Evaluation to contract with outside entities to conduct independent value assessments of approved drugs (i.e., economic analysis of the benefits to patients and the health care system).
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1